Celldex Therapeutics’ $150 Million Common Stock Offering

Lowenstein Sandler represented issuer Celldex Therapeutics, Inc. in the offering. Celldex Therapeutics, Inc. (Celldex) (Nasdaq: CLDX) completed a $150 million public offering of common stock underwritten…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Ambrogio Visconti

This content is for Standard 1 Year members only.
Login Join Now